| Literature DB >> 25313833 |
Imen Mkada-Driss1, Ramzi Lahmadi1, Ahmed S Chakroun1, Chiraz Talbi1, Souheila Guerbouj1, Mehdi Driss1, Elwaleed M Elamine2, Elisa Cupolillo3, Moawia M Mukhtar2, Ikram Guizani1.
Abstract
Visceral leishmaniasis (VL) is mainly due to the Leishmania donovani complex. VL is endemic in many countries worldwide including East Africa and the Mediterranean region where the epidemiology is complex. Taxonomy of these pathogens is under controversy but there is a correlation between their genetic diversity and geographical origin. With steady increase in genome knowledge, RAPD is still a useful approach to identify and characterize novel DNA markers. Our aim was to identify and characterize polymorphic DNA markers in VL Leishmania parasites in diverse geographic regions using RAPD in order to constitute a pool of PCR targets having the potential to differentiate among the VL parasites. 100 different oligonucleotide decamers having arbitrary DNA sequences were screened for reproducible amplification and a selection of 28 was used to amplify DNA from 12 L. donovani, L. archibaldi and L. infantum strains having diverse origins. A total of 155 bands were amplified of which 60.65% appeared polymorphic. 7 out of 28 primers provided monomorphic patterns. Phenetic analysis allowed clustering the parasites according to their geographical origin. Differentially amplified bands were selected, among them 22 RAPD products were successfully cloned and sequenced. Bioinformatic analysis allowed mapping of the markers and sequences and priming sites analysis. This study was complemented with Southern-blot to confirm assignment of markers to the kDNA. The bioinformatic analysis identified 16 nuclear and 3 minicircle markers. Analysis of these markers highlighted polymorphisms at RAPD priming sites with mainly 5' end transversions, and presence of inter- and intra- taxonomic complex sequence and microsatellites variations; a bias in transitions over transversions and indels between the different sequences compared is observed, which is however less marked between L. infantum and L. donovani. The study delivers a pool of well-documented polymorphic DNA markers, to develop molecular diagnostics assays to characterize and differentiate VL causing agents.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25313833 PMCID: PMC4196940 DOI: 10.1371/journal.pone.0109773
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Panel of Leishmania strains used for screening of RAPD markers.
| WHO code | Codes assigned in other studies | Zymodeme | Pathology | Species |
| MHOM/SD/00/MW9 | MON–82 | VL |
| |
| MHOM/SD/00/MW26 | MON–82 | PKDL |
| |
| MHOM/ET/72/GEBRE1 | ARC-11/LEM1005/D28/ARC-43 (LG11) | MON–82 | VL |
|
| MHOM/SD/00/MW106 | ND | VL |
| |
| MHOM/SD/00/MW3 | ND | CL |
| |
| MHOM/TN/93/LV10 | MON–80 | VL |
| |
| MHOM/TN/97/Drep14 | MON–24 | CL |
| |
| MHOM/SA/81/JEDDAH-KA | DON-31/LEM536/D32/DON81 | MON–31 | VL |
|
| MHOM/KE/75/H9 | LEM496/D31 | MON–32 | VL |
|
| MHOM/IN/00/DEVI | DON-09/LEM138/DON39/LG9 | MON–2 | VL |
|
| IMRT/KE/62/LRC-L57 | LEM719/D21 | MON–37 | VL |
|
| MHOM/ET/84/ADDIS164 | LEM980/D29 | MON–83 | VL |
|
WHO that summarizes Host, geographical origin, year of isolation and laboratory code is presented together with pathology and zymodeme code whenever available. MON– corresponds to zymodeme code attributed by the reference center in Montpellier. The table also gathers study codes assigned to some of the isolates in other studies: D21, D28, D29, D31 and D32: strains used in [20]; DON-39 and ARC-43: strains used in [21]; Devi, H9, LRC-L57, ADDIS 164: strains used in [18]; Devi, GEBRE1 and KA-Jeddah: strains used in [53]; DON-81and ARC-43 (LG11): strains used in [28]; DON-09, DON-31, DON-39 and ARC-11: strains used in [25]. Country abbreviations are shown as specified by WHO recommendations (SD: Sudan; TN: Tunisia; ET: Ethiopia; SA: Saudi Arabia; KE: Kenya; IN: India). ND: Not Determined; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; PKDL: Post Kala azar Dermal Leishmaniasis.
Homology analysis of the sequences of the cloned RAPD markers in 3 Leishmania genomes.
| Location | Query coverage | Identity percent | Marker mapping on | Accession number | ||||||||||
| Markers |
|
|
|
|
|
|
|
|
| Gene | Gene hit | Gene | ||
| BPK282A1 | JPCM5 | Friedlin | BPK282A1 | JPCM5 | Friedlin | BPK282A1 | JPCM5 | Friedlin | upstream | downstream | ||||
|
| L1005/220/OPAY8 | LdBK30 | LinJ30 | LmjF30 | 99% | 99% | 98% | 222/225 (99%) | 218/226 (96%) | 200/234 (85%) | LinJ.30.2570 | L.inJ.30.2560 | KJ525724 | |
| LinJ.30.1470 | LinJ.30.1480 | |||||||||||||
| L1005/320/OPAY8 | LdBK30 | LinJ30 | LmjF30 | 99% | 99% | 99% | 257/261 (98%) | 257/261 (98%) | 242/262 (92%) | LinJ.30.1480 | LinJ.30.1419 | KJ525725 | ||
| LinJ.30.1419 | LinJ.30.1500 | |||||||||||||
| L1005/650/OPAY14 | LdBK25 | LinJ25 | LmjF25 | 98% | 98% | 93% | 609/621 (98%) | 613/621 (99%) | 546/597 (91%) | LinJ.25.0630 | KJ525726 | |||
| L1005/1000/OPU10 | LdBK05 | LinJ05 | LmjF05 | 99% | 99% | 93% | 949/980 (97%) | 953/978 (97%) | 441/500 (88%) | LinJ.05.0660 | LinJ.05.0670 | KJ525727 | ||
| M106/950/OPAD17 | LdBK36 | LinJ36 | LmjF36 | 92% | 92% | 51% | 469/481 (98%) | 470/482 (98%) | 412/514 (80%) | LinJ. 36.4750 | LinJ.36.4760 | KJ525728 | ||
| M106/200/OAPY9 | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | KJ525729 | |
|
| LEM138/400/OPAY5 | LdBK20 | LinJ20 | LmjF20 | 98% | 98% | 98% | 380/391 (97%) | 379/391 (97%) | 345/395 (87%) | LinJ.20.1300 | LinJ.20.1310 | KJ525730 | |
| LEM138/550/OPAY14 | LdBK35 | LinJ35 | LmjF35 | 99% | 95% | 84% | 550/552 (99%) | 240/240 (100%) | 484/556 (87%) | LinJ.35.1470 | LinJ.35.1480 | KJ525731 | ||
| LEM536/320/OPAY8 | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | KJ525732 | |
| LEM980/320/OPAY8 | LdBK36 | LinJ36 | LmjF36 | 97% | 97% | 98% | 283/283 (100%) | 280/285 (98%) | 236/286 (83%) | LinJ.36.5800 | LinJ.36.5790 | KJ525733 | ||
| LEM496/300/OPAD17 | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | NF | KJ525734 | |
| LEM719/1000/OPU3 | LdBK23 | LinJ23 | LmjF23 | 99% | 99% | 98% | 956/970 (99%) | 956/970 (99%) | 837/970 (86%) | LinJ.23.1060 | LinJ.23.1050 | KJ525735 | ||
|
| LV10/500/OPAD1 | LdBK20 | LinJ20 | LmjF20 | 98% | 98% | 80% | 436/444 (98%) | 435/444 (98%) | 330/361 (91%) | LinJ.20.1430 | KJ525736 | ||
| LV10/700/OPU10 | LdBK32 | LinJ32 | LmjF32 | 98% | 98% | 97% | 602/608 (99%) | 604/608 (99%) | 547/605 (90%) | LinJ.32.0870 | LinJ.32.0880 | KJ525737 | ||
| LV10/750/OPAY14 | LdBK17 | LinJ17 | LmjF17 | 99% | 99% | 99% | 697/716 (97%) | 705/715 (99%) | 590/714 (83%) | LinJ.17.1550 | LinJ.17.1560 | KJ525738 | ||
| D14/800/OPAD17 | LdBK32 | LinJ32 | LmjF32 | 99% | 99% | 99% | 756/768 (98%) | 759/766 (99%) | 692/785 (88%) | LinJ.32.3230 | LinJ.32.3240 | KJ525739 | ||
| D14/800/OPE2 | LdBK32 | LinJ32 | LmjF32 | 99% | 99% | 99% | 756/768 (98%) | 759/766 (99%) | 692/785 (88%) | LinJ.32.1050 | KJ525740 | |||
| D14/800/OPU10 | LdBK16 | LinJ16 | LmjF16 | 99% | 99% | 99% | 736/743 (99%) | 740/743 (99%) | 720/743 (97%) | LinJ.16.0590 | KJ525741 | |||
| D14/1300/OPAY8 | LdBK29 | LinJ29 | LmjF29 | 99% | 99% | 99% | 698/711 (98%) | 699/711 (98%) | 665/711 (94%) | LinJ.29.1110 | KJ525742 |
NF: Not found. BPK282A1, JPCM5 and Friedlin are names of L. donovani, L. infantum and L. major strains, respectively used for genome sequencing and available in GeneDB.
Figure 1RAPD profiles obtained with primers OP-O7 (A) and OP-O13 (B) to illustrate examples of monomorphic and polymorphic profiles.
Laboratory codes of the strains are indicated for each lane. SD: Sudan; TN: Tunisia; M: 100 bp DNA size marker. Indicated sizes are in bp.
Figure 2UPGMA dendrogram obtained using Nei and Li similarity indexes of the panel of geographically diverse strains using the RAPD profiles generated with a selection of 9 decamers.
Species assignment according to isoenzyme analysis, zymodeme (MON for Montpellier) when available, and country of origin are indicated. ET: Ethiopia; SA: Saudi Arabia; IN: India; KE: Kenya; SD: Sudan; TN: Tunisia.
Figure 3Genomic RFLP analysis using different restriction enzymes and 3 RAPD markers unassigned by in silico analysis.
The hybridization patterns were revealed by the different probes, A: LEM536/320/OPAY8, B: LEM496/300/OPAD17 and C: M106/200/OPAY9. Tested isolates correspond to L. major (FMH; L. maj), L. archibaldi (GEBRE; L. arch), L. donovani (HU3; L. don), L. tropica (DBKM; L. tro) and L. infantum (LEM1163; L. inf). EcoRI, PstI, HindIII, XhoI on top of the panel indicate the restriction enzyme used to digest the total Leishmania DNAs.
Selected features characterizing the cloned RAPD markers.
| Chromosomal assignment | Microsatellites polymorphism in the genomic sites | Mismatch in the priming sites | |||||||
| Markers | Markers |
|
|
|
|
| |||
| 5'–3' | 3'–5' | 5'–3' | 3'–5' | ||||||
| L1005/220/OPAY8 | 30 | (A)8 | (A)9 | (A)10 | (A)3C (A)6 | + | + | + | + |
| L1005/650/OPAY14 | 25 | − | − | − | (G)12 | + | + | + | + |
| (CA)3(CG)2 (CA)5 | (CA)3(CG)2 (CA)5 | (CA)3(CG)2(CA)5 | (CA)12 | ||||||
| (CTCC)3 | (CTCC)3 | (CTCC)3 | (CTCC)3
| ||||||
| (GGA)4
| (GGA)4 | (GGA)4 | (GGA)4A (GGA) 3G11
| ||||||
| L1005/1000/OPU10 | 5 | (C)7 | (C)11 | (C)10 | (d)(C)10 | + | + | + | + |
| (AC)7 | (AC)3GC (AC) 5 | (AC)7 | (AC)8 | ||||||
| (CACCC)3 | (CACCC)3 | (CACCC)3 | (CACCC)3 | ||||||
| (T)10
| (T)10
| (T)10
| (T)10 | ||||||
| (CT)5 | (CT)5 | (CT)6 | (CT)4 | ||||||
| − | − | − | (CCTCTC)3(TC)6 | ||||||
| M106/950/OPAD17 | 36 | (T)10 | (T)10 | (T)9 | (T)10 | + | + | + | + |
| − | − | − | (CTCTCG)3 | ||||||
| (T)9 | (T)10 | (T)11 | − | ||||||
| (TA)5 | (TA)9 | (TA)9 | (TA)16 | ||||||
| LEM138/550/OPAY14 | 35 | (T)10 | (T)10 | (T)10 | (T)12
| + | + | + | + |
| LEM980/320/OPAY8 | 36 | (A)22
| (A)22
| (A)20
| (AAC)6 | + | + | + | + |
| (AC)8 | (AC)8 | (AC)9 | (AC)3 | ||||||
| LEM719/1000/OPU3 | 23 | (GAG) 4 | (GAG)4 | (GAG)4 | GAG | + | + | + | + |
| LV10/500/OPAD1 | 20 | (GT)6 | (GT)6 | (GT)6 | (GT)3
| + | + | + | + |
| (TG)5 | (TG)6 | (TG)6 | − | ||||||
| LV10/750/OPAY14 | 17 | (CA)8 | (CA)3 | (CA)7 | (CA)4
| + | + | − | + |
| (CTTG)3 | − | − | − | ||||||
| D14/800/OPE2 | 32 | (T)3(TG)9 | (T)9(TG)8 | (T)5(TG)6 | (T)6(TG)6 C (TG)7
| + | + | + | + |
| D14/800/OPAD17 | 32 | − | − | − | (GGGA)3 | + | + | + | + |
| LEM138/400/OPAY5 | 20 | − | − | − | − | + | + | + | + |
| L1005/320/OPAY8 | 30 | − | − | − | − | + | + | + | + |
| D14/800/OPU10 | 16 | − | − | − | − | + | + | + | + |
| LV10/700/OPU10 | 32 | − | − | − | − | + | + | + | + |
| D14/1300/OPAY8 | 29 | − | − | − | − | + | + | + | + |
| M106/200/OAPY9 | kDNA | − | − | − | − | NA | NA | NA | NA |
| LEM536/320/OPAY8 | kDNA | − | − | − | − | NA | NA | NA | NA |
| LEM496/300/OPAD17 | kDNA | − | − | − | − | NA | NA | NA | NA |
: Non coding Sequence;
: Overlap with a coding sequence;
: Matching with a coding sequence;
: Minicircle sequence;
* Imperfect Microsatellite: one mutation in one repeat;
**Imperfect Microsatellite: one mutation in two repeats;
*** Imperfect Microsatellite: one mutation in three repeats; (d): a 58 bp deletion associated to the microsatellite; NA: not applicable; −: no microsatellite observed or no mutations at priming site; +: presence of mismatch at priming site.
Comparative inter-species analysis of mutations within the RAPD priming sites.
| Transitions (A-G, T-C) | Transversions (A-T, A-C, G-T, G-C) | Indels | All | ||||||||
| Mutations | Total at 5′end (%) | Total at 3′end (%) | Total (%) | Total at 5′end (%) | Total at 3′end (%) | Total (%) | Total at 5′end (%) | Total at 3′end (%) | Total (%) | Total 5′ | Total 3′ |
|
| 17.95 | 11.54 | 29.49 | 39.74 | 15.38 | 55.12 | 8.97 | 6.41 | 15.38 | 66.66 | 33.33 |
|
| 16.88 | 14.29 | 31.17 | 41.56 | 11.69 | 53.25 | 10.39 | 5.19 | 15.58 | 68.83 | 31.17 |
|
| 13.98 | 22.58 | 36.56 | 34.41 | 16.13 | 50.54 | 7.53 | 5.38 | 12.91 | 55.92 | 44.09 |